"ExoAtlet" gets authorized by Roszdrav
ExoAtlet, the RVC portfolio company, that manufactures medical exoskeletons for rehabilitation, has obtained the marketing authorization from Federal Service of Surveillance in Healthcare
On June 28, 2016 ExoAtlet was registered as medical device in Rozdrav (its registration number РЗН 2016/4360) The authorization was complete at a record pace — in just 8 months.
Similar robotic facilities of foreign origin can be seen in several Russian clinics , but their exorbitant price is inaccessible to the public. Today ExoAtlet is in position to offer its exoskeletons to rehab centres throughout Russia.
In 2014 ExoAtlet reached the final of GenerationS Federal Competition organized by Russian Venture Company . In the same year ExoAtlet won StartupVillage conference, organized by Skolkovo fund. Later that year ExoAtlet became its resident. In November 2015 Moscow Seed Fund jointly with RVC Biofund invested 16 million rubles in ExoAtlet company.
Egor Beketov, Director of RVC Biofund:
After obtaining the marketing authorization, the company has moved to the next stage of its development. Now the first Russian-made exoskeleton is available for people with locomotion disorder. We are pleased to note that the cooperation between ExoAtlet and its investors has managed to introduce to the market a product so badly needed by thousands of Russians. I would not be surprised to see its first operators on the streets of our cities by the end of this year
ExoAtlet project was initiated in 2011 by the Russian Ministry of Emergency Situations and a group of MSU scientists. Eventually, they created a prototype of the first Russian exoskeleton , which was later displayed at IV Integrated Safety & Security Exhibition 2013 " and was awarded a gold medal in the nomination "The best innovative solution in the field of integrated security"
Ekaterina Bereziy, ExoAtlet Founder & CEO
Getting this marketing authorization is like hearing a signal shot from a starting gun before a long distance race. We have a great deal of work ahead of us: organization of sales throughout Russia and participation in clinical trials aimed to develop new medical rehabilitation standards for patients suffering from brain injuries, spinal cord traumas and disseminated sclerosis . Consequently, Russian healthcare will adopt tariffs for treating such patients with the help of exoskeletons in the context of robotic mechanotherapy.
ExoAtlet team comprises professionals who conducted R&D activities within Institute of Mechanics of Moscow State University. During their time with MSU our specialists were involved into research work on creating hardware and software system Exoskeleton under the Federal Target Program aimed at promoting R&D activities of priority science and technology sectors of RF in 2007-2013 " . The team has more than five years of experience of integrating solutions both in design engineering and test performance. They were involved in creating complex mechatronic products of high precision and developing the relevant software and hardware.
